Explain How Suzetrigine Stacks Up for Acute Pain

March 2025

The spotlight is on suzetrigine (Journavx), the first med in a new class of NON-opioid analgesics for acute pain in over 2 decades.

Suzetrigine is a selective sodium channel blocker...that prevents pain signals in the peripheral nervous system from reaching the brain.

It’s NOT a controlled substance...and it doesn’t have warnings about misuse, respiratory depression, etc.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote